A new amyloid-targeting treatment for Alzheimer's disease
from News Medical
With each new amyloid-targeting treatment for Alzheimer's disease that has been developed, there has been a corresponding concern. For example, antibodies targeting amyloid-β peptide (Aβ) produce inflammation in the brain in some patients. Gamma secretase inhibitors tend to produce adverse effects by interacting with Notch, an important pathway for cellular signaling.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063